Head-to-head · WeighScore
iThriveMD vs Premium Health
By GLP-1 ScorecardUpdated
Score comparison
iThriveMD has the higher recorded score — 66.7/100 to 58.8/100.
iThriveMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. iThriveMD is a longevity and metabolic-health clinic (physical locations plus telehealth) offering compounded GLP-1 weight loss — semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs — alongside hormone therapy (HRT/TRT), NAD+, peptides, IV therapy, sexual health, and diagnostic lab testing.
Before you choose
Before comparing the headline prices, the iThriveMD review and the Premium Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, iThriveMD vs Prime Health and Joey Med vs Premium Health compare each of them with another graded program, and the list of alternatives to iThriveMD ranks the programs closest to iThriveMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Oak review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | iThriveMD | Premium Health |
|---|---|---|
| WeighScore | 66.7/100 | 58.8/100 |
| Grade | C | C |
| Site position | #198 | #394 |
| Semaglutide | $299/mo (starting dose, compounded) | $275/mo (all doses, compounded) |
| Tirzepatide | $399/mo (starting dose, compounded) | $445/mo (all doses, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Compounded semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs
- Lab testing and personalized protocols with a medical team; free initial consultation
- Very thorough legal/policy suite (Terms, Privacy, EUA, Shipping, Returns, CCPA)
- Broad longevity menu: hormones (HRT/TRT), NAD+, peptides, IV therapy, sexual health, diagnostics
What to consider
- Premium pricing — higher than budget compounded-GLP-1 competitors (lowest rates need 'preferred pricing')
- Headline GLP-1 pricing is 'starting at'; full cost depends on dose and program length
- Compounding pharmacy partner not named
- LegitScript certification was not documented on the public pages reviewed
FDAWarning letter issued to Premium Health Management Inc. dba Premium Health in February 2026. See the FDA warning-letter database.
Strengths
- All-inclusive membership covers medication, supplies, shipping, and provider visits
- Names three licensed pharmacy partners (Hallandale, Red Rock, Strive)
- Compounded with Vitamin B12 or B6 to aid tolerance
- Free consultation and HIPAA-compliant telehealth via Doxy.me
What to consider
- The LegitScript seal ID published for this provider, #8148613, does not resolve on LegitScript's own CDN — checked August 2026, alongside six seal IDs from other providers that returned normally in the same pass
- Compounded medications are not FDA-approved
- Higher base pricing than many compounded competitors ($275/$445)
- High-dose tiers cost extra ($100-$150/mo)
- FDA issued Premium Health Management Inc. dba Premium Health a warning letter in February 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.